Medtronic Provides Revenue and EPS Guidance for Fiscal Year 2009.(Financial report)

MINNEAPOLIS -- Medtronic, Inc. (NYSE: MDT) today provided revenue and diluted earnings per share (EPS) guidance for fiscal year 2009.

For fiscal year 2009, the Company expects revenue of between $15.0 billion and $15.5 billion at today's foreign exchange rates, and diluted EPS of $2.94 to $3.02.

As in the past, earnings per share estimates exclude the effect of any special or extraordinary charges that may impact the Company's continuing operations and the guidance provided only reflects information available to the Company at this time.

About Medtronic

Medtronic, Inc., headquartered in Minneapolis, is the world's leading medical technology company, alleviating pain, restoring health and extending life for people with chronic disease. Its Internet address is www.medtronic.com

This press release contains forward-looking statements which are subject to risks and uncertainties, such as competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of medical products, government regulation, general economic conditions and other risks and uncertainties described in Medtronic's Annual Report on Form 10-K for the fiscal year ended April 27, 2007. Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements.